Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
Borhani
N O
NO
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000628:therapy; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control / Q000628:therapy; D011322:Primary Prevention; D012008:Recurrence; D012107:Research Design; D012306:Risk; D012907:Smoking
D000319:Adrenergic beta-Antagonists; D008055:Lipids; D004176:Dipyridamole; D002784:Cholesterol; D001241:Aspirin